Gibson Oncology
$1.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Gibson Oncology is currently valued at $35.0M as of July 28, 2025. The company has raised a total of $8.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 4.38x, Gibson Oncology has achieved a valuation that is 4.38 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Gibson Oncology's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Gibson Oncology Worth in 2025?
As of 2025, Gibson Oncology is valued at $35.0M, based on the company's Later Stage VC funding round in July 28, 2025. This valuation positions Gibson Oncology as one of the leading private companies in the sector.
Gibson Oncology Valuation History
Gibson Oncology's funding history demonstrates steady growth and investor confidence.
How Gibson Oncology Valuation is Determined
Private company valuations like Gibson Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Gibson Oncology Valuation FAQs
Is Gibson Oncology profitable?
Gibson Oncology has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Gibson Oncology's valuation compare to competitors?
Gibson Oncology is valued at $35.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Gibson Oncology IPO?
Gibson Oncology has not announced plans for an initial public offering. Until an IPO, investors can access Gibson Oncology shares through secondary market platforms.